Compare OcuNexus Therapeutics vs Momenta Pharmaceuticals
Customers evaluate the quality of OcuNexus Therapeutics's products using the following success metrics.
Overview
OcuNexus Therapeutics is 19 yrs old and is based in United States.
OcuNexus Therapeutics is a development stage biopharmaceutical company that develops treatments for front- and back-of-the-eye diseases and disorders.
Momenta Pharmaceuticals is 23 yrs old and is based in United States.
Momenta Pharmaceuticals (NASDAQ: MNTA) is a biotechnology company with a validated scientific platform focused on discovering and developing biologic therapeutics to treat rare immune-mediated diseases and advancing its late stage biosimilars. On August 19th, 2020, Momenta Pharmaceuticals was acquired by Johnson & Johnson.5B.
Demo Video
Leadership
Brian Levy (Chief Executive Officer)
Alan Crane (Chief Executive Officer)
Funding
Investors
GBS Venture Partners, Domain Associates
Johnson & Johnson, Polaris Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because OcuNexus Therapeutics has not claimed their profile.
Work for OcuNexus Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for OcuNexus Therapeutics?
Claim your profile now.
Information not available because Momenta Pharmaceuticals has not claimed their profile.
Work for Momenta Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Momenta Pharmaceuticals?
Claim your profile now.